osimertinib
astrazeneca
['tagrisso']
#tagrisso is irreversible egfr-tki and has treated more than 600,000 patients worldwide. find more - #globalhealth #esmo22 #esmo2022 #esmo #cancer
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma